Çocukluk Çağı Antibiyotik İlişkili İshalde Probiyotik Kullanımı ve Güncel Öneriler

Sciuto M, Catanzaro R. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases. Acta Microbiol Immunol Hung. 2023; 70: 259-271.

Dahiya D, Nigam PS. Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota- brain axis and cognition: restoration by intake of probiotics and synbiotics. Int J Mol Sci. 2023; 24:3074.

Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance and enteric pathogens. Immunol Rev 2017; 279: 90-105.

Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023; 10: 20499361231154443.

Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ. 2002; 324:1345–6.

Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346:334–339.

Hayes SR, Vargas AJ. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Explore (NY). 2016; 12: 463–466.

Zheng Y, Wu Q, Fang F, Chen J, Shang Y, Fu Z, et al. Expert consensus on diagnosis, treatment and prevention of antibiotic-associated diarrhea in children. Chin J Appl Clin Pediatr. 2021; 36, 424–430.

Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensu statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11:506-514.

Hojsak I. Probiotics in children. What is the evidence? Pediatr Gastroenterol Hepatol Nutr. 2017; 20: 139-146.

Depoorter L, Vandenplas Y. Probiotics in pediatrics. A review and practical guideline. Nutrients. 2021; 13(7): 2176.

Mekonnen SA, Merenstein D, Fraser CM, Marco ML. Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea. Curr Opin Biotechnol. 2020; 61: 226-234.

Kopacz K, Phadtare S. Probiotics for the prevention of antibiotic-associated diarrhea. Healthcare (Basel). 2022; 10(8):1450.

Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, Cokugras FC, et al. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Pediatr. 2018; 107: 927-937.

Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr. 2016; 62(3): 495-506.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019; 4(4):CD004827.

Szajewska H, Canani RB, Domellöf B, Guarino A, Hojsak I, Indrio F, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications. J Pediatr Gastroenterol Nutr. 2023; 76(2):232-247.

Yang Q, Hu Z, Lei Y, Li X, Xu C, Zhang J, et al. Overview of systematic reviews of probiotics in prevention and treatment of antibiotic-associated diarrhea in children. Front Pharmacol. 2023; 14: 1153070.

Cameron D, Hock QS, Kadim M, Mohan N, Ryoo E, Sandhu B, et al. Probiotics for gastrointestinal disorders: proposed recommendations for children of the Asia-Pacific region. World J Gastroenterol. 2017; 23: 7952-7964.

Yaccha SK, Sarma MS, Mohan N, Wadhwa N, Kumar Vr N, Srinivasan R, et al. Indian academy of pediatrics consensus guidelines for probiotic use in childhood diarrhea. Indian Pediatr. 2022; 59: 543-551.

Gopalan S, Ganapathy S, Mitra M, Neha, Kumar Joshi D, Veligandla KC, et al. Unique properties of yesat probiotic sacchromyces boulardii CNCM-I 745: a narrative review. Cureus. 2023; 15(10): e46314.

Sciuto M, Catanzaro R. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases. Acta Microbiol Immunol Hung. 2023; 70: 259-271.

Dahiya D, Nigam PS. Antibiotic-therapy-induced gut dysbiosis affecting gut microbiota- brain axis and cognition: restoration by intake of probiotics and synbiotics. Int J Mol Sci. 2023; 24:3074.

Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance and enteric pathogens. Immunol Rev 2017; 279: 90-105.

Kesavelu D, Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management. Ther Adv Infect Dis. 2023; 10: 20499361231154443.

Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ. 2002; 324:1345–6.

Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346:334–339.

Hayes SR, Vargas AJ. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Explore (NY). 2016; 12: 463–466.

Zheng Y, Wu Q, Fang F, Chen J, Shang Y, Fu Z, et al. Expert consensus on diagnosis, treatment and prevention of antibiotic-associated diarrhea in children. Chin J Appl Clin Pediatr. 2021; 36, 424–430.

Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensu statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11:506-514.

Hojsak I. Probiotics in children. What is the evidence? Pediatr Gastroenterol Hepatol Nutr. 2017; 20: 139-146.

Depoorter L, Vandenplas Y. Probiotics in pediatrics. A review and practical guideline. Nutrients. 2021; 13(7): 2176.

Mekonnen SA, Merenstein D, Fraser CM, Marco ML. Molecular mechanisms of probiotic prevention of antibiotic-associated diarrhea. Curr Opin Biotechnol. 2020; 61: 226-234.

Kopacz K, Phadtare S. Probiotics for the prevention of antibiotic-associated diarrhea. Healthcare (Basel). 2022; 10(8):1450.

Hojsak I, Fabiano V, Pop TL, Goulet O, Zuccotti GV, Cokugras FC, et al. Guidance on the use of probiotics in clinical practice in children with selected clinical conditions and in specific vulnerable groups. Acta Pediatr. 2018; 107: 927-937.

Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, et al. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr. 2016; 62(3): 495-506.

Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019; 4(4):CD004827.

Szajewska H, Canani RB, Domellöf B, Guarino A, Hojsak I, Indrio F, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN special interest group on gut microbiota and modifications. J Pediatr Gastroenterol Nutr. 2023; 76(2):232-247.

Yang Q, Hu Z, Lei Y, Li X, Xu C, Zhang J, et al. Overview of systematic reviews of probiotics in prevention and treatment of antibiotic-associated diarrhea in children. Front Pharmacol. 2023; 14: 1153070.

Cameron D, Hock QS, Kadim M, Mohan N, Ryoo E, Sandhu B, et al. Probiotics for gastrointestinal disorders: proposed recommendations for children of the Asia-Pacific region. World J Gastroenterol. 2017; 23: 7952-7964.

Yaccha SK, Sarma MS, Mohan N, Wadhwa N, Kumar Vr N, Srinivasan R, et al. Indian academy of pediatrics consensus guidelines for probiotic use in childhood diarrhea. Indian Pediatr. 2022; 59: 543-551.

Gopalan S, Ganapathy S, Mitra M, Neha, Kumar Joshi D, Veligandla KC, et al. Unique properties of yesat probiotic sacchromyces boulardii CNCM-I 745: a narrative review. Cureus. 2023; 15(10): e46314.